Chester County News and Community Website
ATLANTA, GA — The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) concluded a two-day meeting this past week at CDC headquarters, voting on several …
ACIP Issues Vaccine Recommendations, Commits to Public Health Transparency Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has taken a bold step to restore public trust by reconstituting the Advisory Committee for Immunization Practices (ACIP), …
HHS Overhauls Vaccine Advisory Committee to Restore Public Trust Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS), in collaboration with the National Institutes of Health (NIH), has unveiled a revolutionary initiative aimed at reshaping pandemic …
HHS and NIH Unveil Groundbreaking Universal Vaccine Platform Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has launched an ambitious and hard-hitting initiative designed to counteract misinformation and empower parents with the truth about childhood …
HHS Declares War on Misinformation with the Groundbreaking ‘Let’s Get Real’ Campaign Read More
WASHINGTON, D.C. — In a decisive move to bolster the global fight against the mpox outbreak, the U.S. Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness …
HHS Boosts Global Mpox Vaccine Supply Amid Ongoing Public Health Threat Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved FluMist for self- or caregiver-administration, expanding accessibility for influenza prevention. FluMist, designed to combat influenza virus subtypes A and …
FDA Greenlights FluMist for Self- and Caregiver-Administration Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has unveiled a new national campaign titled ‘Risk Less. Do More.’ This initiative aims to educate the public on …
HHS Launches ‘Risk Less. Do More.’ Campaign to Boost Vaccine Awareness Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) this week approved a new vaccine, Capvaxive, to combat invasive diseases and pneumonia caused by Streptococcus pneumoniae in adults. This approval …
FDA Approves New Pneumococcal Vaccine for Adults Read More
WASHINGTON, D.C. — The Biomedical Advanced Research and Development Authority (BARDA) has announced up to $500 million in funding under Project NextGen to advance clinical trials of novel COVID-19 vaccines …
BARDA Allocates $500 Million for Innovative COVID-19 Vaccine Trials Read More
KING OF PRUSSIA, PA — Biotechnology giants CSL and Arcturus Therapeutics have announced promising results from a comprehensive study of their novel COVID-19 vaccine, ARCT-154. The findings, published in Nature …
CSL and Arcturus Announce Breakthrough COVID-19 Vaccine Study Results Read More